CBIO Chart
- 52-Week Range: $0.36 - $5.18
- Market Capitalization: $37.62M
- Short Percentage: 0%
- Target Price: $11.33
- Shares Outstanding: 31.48M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
CBIO released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Catalyst Biosciences Reports First Quarter 2022 Operating & Financial ResultsGlobeNewsWire | May 9th
- Catalyst Biosciences Engages Perella Weinberg Partners to Assist the Company in Exploring Strategic AlternativesGlobeNewsWire | February 17th
- Catalyst Biosciences to Present at the Piper Sandler 33rd Annual Virtual Healthcare ConferenceGlobeNewsWire | November 22nd
- Catalyst Biosciences Announces CFI Variant Presentations at Two Upcoming Scientific ConferencesGlobeNewsWire | October 29th
- FDA Grants Catalyst Biosciences Orphan Drug Designation for MarzAA for the Treatment of Factor VII DeficiencyGlobeNewsWire | September 28th
- Catalyst Biosciences to Present at the Cantor Global Healthcare ConferenceGlobeNewsWire | September 24th
Company Info
Website: https://www.catalystbiosciences.com
Address: 611 Gateway Boulevard, South San Francisco, CA, United States, 94080
Sector: Healthcare
Industry: Biotechnology
Full time employees: 45
Address: 611 Gateway Boulevard, South San Francisco, CA, United States, 94080
Sector: Healthcare
Industry: Biotechnology
Full time employees: 45
$CBIO It's happening!
$CBIO if your selling dont regret it later
$CBIO what calls are you guys jacked to the tits on?
$CBIO She's gettin' ready to...
$CBIO cup and handle forming
$CBIO just added more
$CBIO is anyone really buying this shit
$CBIO who else excited??